Brown and colleagues1 reported the results of a systematic review of the literature aimed in determining whether greater extent of resection (EOR) is associated with improved 1- and 2-year overall survival and 6-month and 1-year progression-free survival in patients affected by glioblastoma multiforme. The analysis revealed 37 studies suitable for inclusion. The authors found that gross total resection (GTR) for glioblastoma multiforme reduces 1- and 2-year mortality, thus supporting GTR over subtotal resection and biopsy.

Grasso, G. (2016). Extent of resection and survival in glioblastoma multiforme. JAMA ONCOLOGY, 2(11), 1508-1509 [10.1001/jamaoncol.2016.3806].

Extent of resection and survival in glioblastoma multiforme

Grasso, G.
2016-01-01

Abstract

Brown and colleagues1 reported the results of a systematic review of the literature aimed in determining whether greater extent of resection (EOR) is associated with improved 1- and 2-year overall survival and 6-month and 1-year progression-free survival in patients affected by glioblastoma multiforme. The analysis revealed 37 studies suitable for inclusion. The authors found that gross total resection (GTR) for glioblastoma multiforme reduces 1- and 2-year mortality, thus supporting GTR over subtotal resection and biopsy.
2016
Grasso, G. (2016). Extent of resection and survival in glioblastoma multiforme. JAMA ONCOLOGY, 2(11), 1508-1509 [10.1001/jamaoncol.2016.3806].
File in questo prodotto:
File Dimensione Formato  
jama oncology.pdf

Solo gestori archvio

Tipologia: Post-print
Dimensione 69.47 kB
Formato Adobe PDF
69.47 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/397666
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 14
social impact